Literature DB >> 18571922

Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.

Adrian Hall1, Andy Billinton, Alan K Bristow, Susan H Brown, Anita Chowdhury, Leanne Cutler, Gerard M P Giblin, Paul Goldsmith, Thomas G Hayhow, Ian R Kilford, Alan Naylor, Barry Passingham, D Anthony Rawlings.   

Abstract

We describe the discovery of a series of pyrazole amide EP(1) receptor antagonists with good aqueous solubility and CNS penetration. In order to achieve solubility we investigated the incorporation of a basic group in the region of the molecule previously occupied by a carboxylic acid, which was known to be a key element of the pharmacophore. This study led to the identification of compounds such as 4h, 4j and 10b which demonstrated brain-to-blood ratios of 0.8:1-2.0:1 in addition to good solubility and metabolic stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571922     DOI: 10.1016/j.bmcl.2008.05.118

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.

Authors:  Jason D Downey; Sam A Saleh; Thomas M Bridges; Ryan D Morrison; J Scott Daniels; Craig W Lindsley; Richard M Breyer
Journal:  Bioorg Med Chem Lett       Date:  2012-11-24       Impact factor: 2.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.